Perspective Therapeutics (CATX) Accumulated Depreciation (2011 - 2026)

Perspective Therapeutics (CATX) has 14 years of Accumulated Depreciation data on file, last reported at $7.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation rose 98.59% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (up 98.59% YoY), and the FY2025 full-year result was $6.2 million, up 109.59% from the prior year.
• Accumulated Depreciation climbed to $7.3 million in Q1 2026, from $6.2 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $8.3 million in Q3 2023 to a low of $15000.0 in Q4 2022.
• A 5-year average of $4.8 million and a median of $5.2 million in 2025 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation plunged 99.8% in 2022 and surged 4360.0% in 2023, its largest moves.
• Tracing CATX's Accumulated Depreciation over 5 years: stood at $15000.0 in 2022, then surged by 4360.0% to $669000.0 in 2023, then surged by 342.45% to $3.0 million in 2024, then jumped by 109.59% to $6.2 million in 2025, then grew by 18.12% to $7.3 million in 2026.
• Business Quant data shows CATX's Accumulated Depreciation at $7.3 million in Q1 2026, $6.2 million in Q4 2025, and $5.2 million in Q3 2025.